MAPK3 and asthma: In conclusion, the data presented in this study shows that inhibition of Src/EGRF/ERK1/2 is one of the mechanisms by which the Ang-(1–7)/ MAS1 receptor axis mediates its anti-inflammatory and anti-AHR effects in inflammatory diseases such as asthma.